Sleep Apnea Reduced in People Who Took Zepbound, Eli Lilly Reports
The company reported results of clinical trials involving Zepbound, an obesity drug in the same class as Novo Nordisk’s Wegovy.

Join our subscribers list to get the latest news, updates and special offers directly in your inbox
usnews Jul 4, 2024 0 239
usnews Jul 4, 2024 0 236
usnews Jul 4, 2024 0 236
usnews Jul 4, 2024 0 232
usnews Jul 4, 2024 0 230